Clinical Trial Update: Odronextamab in Low Tumor Volume Advanced FL [Phase 2]

View source ↗

Summary

Phase 2 study evaluating odronextamab for low-tumor-volume advanced follicular lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Odronextamab (odronextamab)

Snippet

Sponsor: Gottfried von Keudell, MD PhD | Conditions: Follicular Lymphoma, Lymphoma | Phase 2 | Status: RECRUITING